Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso
Palpouguini Lompo(London School of Hygiene & Tropical Medicine), Halidou Tinto(Institut de Recherche en Sciences de la Santé), Ashmed Cheick Bachirou Nana(Institut de Recherche en Sciences de la Santé), Adama Kazienga(Institut de Recherche en Sciences de la Santé), Hamtandi Magloire Natama(Research Institute of Health Sciences), Marc Christian Tahita(Serum Institute of India (India)), Isidore Juste O. Bonkoungou(Université Joseph Ki-Zerbo), Hermann Sorgho(Institut de Recherche en Sciences de la Santé), William Christian Kaboré(Institut de Recherche en Sciences de la Santé), Nicolas Barro(Université Joseph Ki-Zerbo)
Cited by 11
Related Papers
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345